Possible reduction of cardiac risk after supplementation with epigallocatechin gallate and increase of ketone bodies in the blood in patients with multiple sclerosis. A pilot study

  1. Benlloch, M.
  2. Cuerda‐ballester, M.
  3. Drehmer, E.
  4. Platero, J.L.
  5. Carrera‐juliá, S.
  6. López‐rodríguez, M.M.
  7. Ceron, J.J.
  8. Tvarijonaviciute, A.
  9. Navarro, M.Á.
  10. Moreno, M.L.
  11. Ortí, J.E.L.R.
Revue:
Nutrients

ISSN: 2072-6643

Année de publication: 2020

Volumen: 12

Número: 12

Pages: 1-14

Type: Article

DOI: 10.3390/NU12123792 GOOGLE SCHOLAR lock_openAccès ouvert editor